James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 5,401 shares at $21.18 ($114K) on 2026-05-26, disclosed to the SEC on 2026-05-27.
Seasonal sale ($114k) by PRINCIPAL ACCOUNTING OFFICER — this insider has traded ACAD in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $193K | — | Filing → |